简 EN 繁
简 EN 繁

Please enter the information you want to find

Hot key words：
Hyaluronidase xxx
News Center News Center

News Center

2025.05.16

【News】Bao Pharma's Recombinant Human Hyaluronidase Successfully Registered in the U.S. FDA DMF

View details
【News】Bao Pharma's Recombinant Human Hyaluronidase Successfully Registered in the U.S. FDA DMF
[News] KJ103 (Recombinant Immunoglobulin G-degrading Enzyme Ricefidase for injection) Designated as a Breakthrough Therapy
2024.11.20

[News] KJ103 (Recombinant Immunoglobulin G-degrading Enzyme Ricefidase for injection) Designated as a Breakthrough Therapy

View details
[News] Bao Pharma's "KJ103 for Injection" (Recombinant Immunoglobulin G-degrading Enzyme Ricefidase) Receives Clinical Trial Approval from NMPA
2024.08.22

[News] Bao Pharma's "KJ103 for Injection" (Recombinant Immunoglobulin G-degrading Enzyme Ricefidase) Receives Clinical Trial Approval from NMPA

View details
[News] The Investigator Meeting for the Phase II Clinical Trial of KJ103 (Recombinant Immunoglobulin G-degrading Enzyme Ricefidase for injection) for Anti-GBM Disease Successfully Concludes
2024.07.22

[News] The Investigator Meeting for the Phase II Clinical Trial of KJ103 (Recombinant Immunoglobulin G-degrading Enzyme Ricefidase for injection) for Anti-GBM Disease Successfully Concludes

View details
[News] Centergene Receives Clinical Trial Approval for Recombinant Human Chorionic Gonadotropin Injection from the National Medical Products Administration
2024.05.17

[News] Centergene Receives Clinical Trial Approval for Recombinant Human Chorionic Gonadotropin Injection from the National Medical Products Administration

View details
12